The position of loco-regional therapy in the management of hepatocellular carcinoma with extrahepatic metastases.
作者信息
Kim Beom Kyung
机构信息
Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Korea.
Institute of Gastroenterology, Yonsei University College of Medicine, Seoul, Korea.
出版信息
J Liver Cancer. 2024 Sep;24(2):129-130. doi: 10.17998/jlc.2024.08.26. Epub 2024 Aug 29.
Abstract
摘要
相似文献
1
The position of loco-regional therapy in the management of hepatocellular carcinoma with extrahepatic metastases.局部区域治疗在伴有肝外转移的肝细胞癌管理中的地位。
J Liver Cancer. 2024 Sep;24(2):129-130. doi: 10.17998/jlc.2024.08.26. Epub 2024 Aug 29.
2
Loco-regional intervention for hepatocellular carcinoma.肝细胞癌的局部区域干预
J Interv Med. 2019 Jul 30;2(2):43-46. doi: 10.1016/j.jimed.2019.07.001. eCollection 2019 May.
3
Spermatic Cord and Peritoneal Metastases from Unruptured Hepatocellular Carcinoma.未破裂肝细胞癌的精索和腹膜转移
J Clin Diagn Res. 2015 Oct;9(10):TD04-5. doi: 10.7860/JCDR/2015/13115.6650. Epub 2015 Oct 1.
4
The effect of loco-regional control on distant metastatic dissemination in carcinoma of the nasopharynx: an analysis of 1301 patients.局部区域控制对鼻咽癌远处转移扩散的影响：1301例患者的分析
Int J Radiat Oncol Biol Phys. 1994 Dec 1;30(5):1029-36. doi: 10.1016/0360-3016(94)90306-9.
5
Downstaging and resection of hepatocellular carcinoma in patients with extrahepatic metastases after stereotactic therapy.立体定向治疗后肝外转移患者肝细胞癌的降期与切除
Hepatobiliary Surg Nutr. 2021 Aug;10(4):434-442. doi: 10.21037/hbsn-21-188.
6
Outcomes associated with the intention of loco-regional therapy prior to living donor liver transplantation for hepatocellular carcinoma.肝细胞癌活体肝移植术前局部区域治疗意向相关的结局
World J Gastrointest Surg. 2020 Jan 27;12(1):17-27. doi: 10.4240/wjgs.v12.i1.17.
7
A rare and challenging case of extrahepatic costal metastases from an unknown primary hepatocellular carcinoma.一例罕见且具有挑战性的原发性不明肝细胞癌肝外肋骨转移病例。
Gastroenterol Hepatol Bed Bench. 2024;17(1):93-99. doi: 10.22037/ghfbb.v17i1.2812.
8
An overview of loco-regional treatments in patients and mouse models for hepatocellular carcinoma.局部区域治疗在肝癌患者和小鼠模型中的概述。
Infect Agent Cancer. 2015 Mar 9;10:9. doi: 10.1186/s13027-015-0004-2. eCollection 2015.
9
18F-FDG PET in the detection of extrahepatic metastases from hepatocellular carcinoma.18F-FDG正电子发射断层显像在肝细胞癌肝外转移灶检测中的应用
J Gastroenterol. 2004 Oct;39(10):961-8. doi: 10.1007/s00535-004-1427-5.
10
Efficacy of surgical resection in management of isolated extrahepatic metastases of hepatocellular carcinoma.手术切除治疗肝细胞癌肝外孤立转移的疗效。
World J Gastroenterol. 2009 Nov 21;15(43):5481-8. doi: 10.3748/wjg.15.5481.
引用本文的文献
1
Primary small cell-like hepatocellular carcinoma arising in a patient with fatty liver disease without cirrhosis: a case report and literature review.非肝硬化性脂肪性肝病患者中发生的原发性小细胞样肝细胞癌：一例报告及文献复习
Gastroenterol Rep (Oxf). 2025 Jul 19;13:goaf061. doi: 10.1093/gastro/goaf061. eCollection 2025.
本文引用的文献
1
A Prospective, Single-Arm, Phase 2 Study of Modified Transarterial Chemoembolization Using Low-Dose Chemotherapy with Blank Microspheres Plus Low-Dose Lenvatinib and Microwave Ablation in Patients with Large (≥7 cm) Unresectable Hepatocellular Carcinoma: The TALEM Trial.一项针对大尺寸（≥7厘米）不可切除肝细胞癌患者的前瞻性单臂2期研究，该研究采用低剂量化疗与空白微球联合低剂量乐伐替尼及微波消融进行改良经动脉化疗栓塞：TALEM试验
Liver Cancer. 2024 Jan 29;13(4):438-450. doi: 10.1159/000536518. eCollection 2024 Aug.
2
Transarterial Chemoembolization Combined with Atezolizumab Plus Bevacizumab versus Transarterial Chemoembolization Alone in Intermediate-stage Hepatocellular Carcinoma: A Multicenter Retrospective Study.经动脉化疗栓塞联合阿替利珠单抗加贝伐单抗与单纯经动脉化疗栓塞治疗中期肝细胞癌的多中心回顾性研究
J Hepatocell Carcinoma. 2024 Jun 12;11:1079-1093. doi: 10.2147/JHC.S461630. eCollection 2024.
3
Role of transarterial chemoembolization for hepatocellular carcinoma with extrahepatic metastases in the era of advancing systemic therapy.在全身治疗不断发展的时代，经动脉化疗栓塞术在伴有肝外转移的肝细胞癌中的作用
J Liver Cancer. 2024 Sep;24(2):243-252. doi: 10.17998/jlc.2024.05.26. Epub 2024 Jun 3.
4
Evaluation of the Clinical Efficacy of Intensity-Modulated Radiotherapy Combined with Transcatheter Arterial Chemoembolization for Hepatocellular Carcinoma with Extrahepatic Oligometastasis and Prognostic Factors for Patient Survival.调强放射治疗联合经动脉化疗栓塞治疗肝外寡转移肝细胞癌的临床疗效及患者生存预后因素评估
Int J Gen Med. 2023 Apr 12;16:1271-1278. doi: 10.2147/IJGM.S403316. eCollection 2023.
5
Clinical practice guideline and real-life practice in hepatocellular carcinoma: A Korean perspective.肝细胞癌的临床实践指南与实际临床实践：韩国视角。
Clin Mol Hepatol. 2023 Apr;29(2):197-205. doi: 10.3350/cmh.2022.0404. Epub 2023 Jan 5.
6
Stereotactic Ablative Radiotherapy for Oligometastatic Hepatocellular Carcinoma: A Multi-Institutional Retrospective Study (KROG 20-04).立体定向消融放疗治疗寡转移性肝细胞癌：一项多机构回顾性研究（KROG 20-04）
Cancers (Basel). 2022 Nov 27;14(23):5848. doi: 10.3390/cancers14235848.
7
2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma.2022 KLCA-NCC 韩国肝细胞癌管理实践指南。
Clin Mol Hepatol. 2022 Oct;28(4):583-705. doi: 10.3350/cmh.2022.0294. Epub 2022 Oct 1.
8
Clinical Outcomes with Multikinase Inhibitors after Progression on First-Line Atezolizumab plus Bevacizumab in Patients with Advanced Hepatocellular Carcinoma: A Multinational Multicenter Retrospective Study.一线阿替利珠单抗联合贝伐单抗治疗进展后使用多激酶抑制剂治疗晚期肝细胞癌患者的临床结局：一项多国多中心回顾性研究
Liver Cancer. 2021 Apr;10(2):107-114. doi: 10.1159/000512781. Epub 2021 Mar 3.
9
Survival benefit of transarterial chemoembolization in patients with metastatic hepatocellular carcinoma: a single center experience.经动脉化疗栓塞术对转移性肝细胞癌患者的生存获益：单中心经验
BMC Gastroenterol. 2017 Aug 10;17(1):98. doi: 10.1186/s12876-017-0656-z.
10
Management of patients with hepatocellular carcinoma and extrahepatic metastasis.肝细胞癌合并肝外转移患者的管理。
Dig Dis. 2011;29(3):333-8. doi: 10.1159/000327572. Epub 2011 Aug 9.
Zotero 插件